title: Left ventricular ejection fraction in advanced cancer patients: a valuable prognostic tool?
authors.affiliation: Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Unit 455, 1515 Holcombe Boulevard, Houston, TX 77030, USA.|Department of Internal Medicine, University of Texas Health Science Center at Houston, Houston, TX 77030, USA.
authors.forename: Rabih
authors.initials: R
authors.lastname: Said
authors.affiliation: Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Unit 455, 1515 Holcombe Boulevard, Houston, TX 77030, USA.
authors.forename: Apostolia M
authors.initials: AM
authors.lastname: Tsimberidou
mesh_terms: D002318:Cardiovascular Diseases / Q000175:diagnosis / Q000209:etiology*; D004562:Electrocardiography; D006801:Humans; D009369:Neoplasms / Q000503:physiopathology* / Q000628:therapy; D018487:Ventricular Dysfunction, Left / Q000175:diagnosis / Q000503:physiopathology; D016277:Ventricular Function, Left
keywords: LVEF; cardio-oncology; cardiomyopathy; chemotherapy; targeted therapy